4C Medical Technologies, Inc. Email Format

Biotechnology ResearchMinnesota, United States51-200 Employees

4C Medical Technologies, Inc. is a biotechnology-driven medical device company focused on minimally invasive therapies for structural heart disease. Its approach to mitral regurgitation uses a transcatheter device positioned supra annularly to stop leakage from the left atrium, with atrial-only fixation designed to minimize disruption to the left ventricle and related structures. The company aims to address MR without replacing the native valve, with plans to extend the method to tricuspid regurgitation.

Headquartered in Maple Grove, Minnesota, the firm operates as a mid-sized player in the biotechnology research space. It has historical work around the AltaValve transcatheter mitral valve replacement platform, reflecting its broader focus on percutaneous solutions for structural heart disease.

Sign up for free to view info

Company overview Employee directory